Shortages remain despite regulatory, industry actions

11/18/2012 | New York Times (tiered subscription model), The

Drug shortages have prompted a presidential order, congressional hearings and promises of improved communication from makers of generic drugs. About 150 new shortages have been prevented, according to the FDA. "We're seeing real change in the number of shortages that we're able to recognize early," FDA Commissioner Dr. Margaret Hamburg said. However, the shortages are not going away because a drug tends to remain scarce once it becomes scarce, said Erin Fox, who tracks drug supplies at the University of Utah.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs: